A Trial Of Intravenous N-Acetylcysteine In The Management Of Antituberculous Drug-Induced Hepatitis
Status:
Completed
Trial end date:
2019-02-01
Target enrollment:
Participant gender:
Summary
We will conduct a randomized placebo controlled trial to determine whether administration of
intravenous (IV) NAC to participants with TB DIH, in dosages similar to that used in
paracetamol poisoning, can improve recovery from hepatotoxicity.